Issue 6 2021

The latest edition of Modern Medicine is now available for you to read. We have some great articles featured in this edition:

  • Ethics (CPD) – Walking the tightrope of beneficial or harmful prescribing practices
  • Pulmonology (CPD) – COPD Exacebations- A hearty opportunity
  • Asthma – International opinion on nebulisation during COVID
  • Osteoporosis (CPD) – Managing Osteoporosis and Fragility fractures- An Italian perspective
  • … and many more !

Also, a reminder that, not only do we have CPD questions available within the magazine itself, we also have an online CPD portal that allows you to score even more points by simply completing your test online

Modern Medicine, the journal that’s with you wherever you go.

Hyaluronic Acid: A Lasting Treatment for Osteoarthritic Joints

Hyaluronic Acid: A Lasting Treatment for Osteoarthritic Joints

Osteoarthritis is a chronic degenerative joint disease characterised by pain and progressive functional limitation. Viscosupplementation with intra-articular hyaluronic acid is a treatment option in knee OA that is included in various professional guidelines for the treatment of this joint disease, but potentially could apply to all synovial joints in order to reduce pain and improve joint lubrication.

Modern Medicine – Issue 6 2021

Neuro-modulation: A New Approach to HF

Neuro-modulation: A New Approach to HF

Heart failure (HF) is a complex clinical syndrome characterised by abnormalities in cardiac structure and function, dynamic remodelling, and perturbations of the neurohormonal axis. recently, the concept of neuro-modulation, rather than neuro-inhibition, has been successfully tested with the angiotensin receptor neprilysin inhibitor (arni) class representing a potential shift in the treatment of HF from partial neurohormonal system inhibition to an integrated composite neurohormonal system modulation.

Modern Medicine – Issue 6 2021

Controlling Triglycerides in Type 2 Diabetes Cuts CVD Risk

Controlling Triglycerides in Type 2 Diabetes Cuts CVD Risk

Hypertriglyceridaemia is a prevalent risk factor for cardiovascular disease (CVD) and increasingly important in the setting of current obesity and insulin resistance epidemics. Statins are the primary drug treatment option, however, trial data show substantial ‘residual risk’ in people with type 2 diabetes (T2D) who are on statin treatment. This indicates that preventative treatment with statins alone may not be enough in people with T2D and additional therapies, such as fibrates, may need to be considered.

Modern Medicine – Issue 6 2021

Common skin problems in children Managing atopic dermatitis

Common skin problems in children Managing atopic dermatitis

Atopic dermatitis (AD) is common in children, with severity ranging from trivial to life-ruining. Itch and associated sleep loss impact quality of life. Environmental modification, topical emollients and topical corticosteroids are key, but corticosteroid phobia impedes treatment. Allergy testing is often requested, but is usually unnecessary and does not change management. When a child fails to respond to treatment , consider noncompliance, infection, allergy or combination with another dermatosis, most often psoriasis. The prognosis for AD is good, with most children recovering by the end of primary school.

Modern Medicine – Issue 6 2021

Taking a Good History is Crucial in Ménière’s Disease

Taking a Good History is Crucial in Ménière’s Disease

Ménière’s disease is an endolymphatic hydroplasty that develops in the inner ear as a result of overproduction or inadequate reabsorption of endolymph. This hydrops is clinically characterised by vertigo in the form of attacks on the affected side, sensorineural hearing loss showing fluctuations at low to medium frequencies, tinnitus and fullness. The duration of the attack is between 20min and 24h.

Modern Medicine – Issue 6 2021

Managing Irregular Menstrual Cycles Brings Benefits

Managing Irregular Menstrual Cycles Brings Benefits

Regularity of menstrual cycles is considered an indicator of women’s reproductive health; changes in the menstrual cycle have different reasons and are often attributed to ovaries-thyroid and pituitary axis dysfunctions. Secondary amenorrhoea is characterised by cessation of previously regular menses for three months or previously irregular menses for six months and warrants evaluation. Dydrogesterone has been shown to effectively induce withdrawal bleeding and maintain regular bleeding in women with secondary amenorrhoea and normal oestrogen levels.

Modern Medicine – Issue 6 2021

Diagnosing and Managing Lactose Intolerance

Diagnosing and Managing Lactose Intolerance

Lactose intolerance is a relatively new disease increasingly recognised in medicine in the last 50 years, although the symptoms were described by Hippocrates more than 2000 years ago. In the 1960s, research revealed that lactose intolerance was correlated with race and that lactose intolerance was more common globally than lactose tolerance. More recently, genetic causes of lactose intolerance have been identified.

Modern Medicine – Issue 6 2021